01 36VIIV HLTHCARE
01 17125879
02 88129385
03 89242986
04 110426780
05 111234985
06 112011506
07 88129385*PED
08 89242986*PED
01 18Y
02 18Blank
01 20Y
02 16Blank
01 12025-04-21
02 82027-10-05
03 82028-04-05
04 82029-12-08
05 82030-06-08
06 22031-01-24
07 12038-09-05
Patent Expiration Date : 2025-04-21
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2031-01-24
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 10426780
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2031-01-24
Patent Expiration Date : 2031-01-24
DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 11234985
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211994
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2031-01-24
Patent Expiration Date : 2027-10-05
US Patent Number : 8129385
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-10-05
Patent Expiration Date : 2029-12-08
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205551
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2027-10-05
US Patent Number : 8129385
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-10-05
Patent Expiration Date : 2029-12-08
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 213983
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2027-10-05
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 8129385
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205551
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-10-05
LOOKING FOR A SUPPLIER?
